Results
1 -
10 of
23Biomarkers for Antipsychotic Therapies, Current Antipsychotics Translating the Glutamatergic Hypothesis of Schizophrenia Through Homeostatic Regulation of Brain Glycine, Psychiatry and Neuroscience Update Assessment of a glycine uptake inhibitor in animal models of effort-related choice behavior: implications for motivational dysfunctions, Psychopharmacology A Review of the Pharmacology, Efficacy and Tolerability of Recently Approved and Upcoming Oral Antipsychotics: An Evidence-Based Medicine Approach, CNS Drugs Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders, European Archives of Psychiatry and Clinical Neuroscience Targeting glutamate to treat schizophrenia: lessons from recent clinical studies, Psychopharmacology The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey, Psychopharmacology GlyT-1 Inhibitors: From Hits to Clinical Candidates, Small Molecule Therapeutics for Schizophrenia Pharmacotherapy Through the Inhibition of Glycine Transporters: An Update on and Beyond Schizophrenia, Psychiatry and Neuroscience Update - Vol. II